Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
Status:
RECRUITING
Trial end date:
2028-04-26
Target enrollment:
Participant gender:
Summary
To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).